Morel P - Search Results

1

Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.

Célestin Schartz NE, Chevret S, Paz C, Kerob D, Verola O, Morel P, Lebbé C. Célestin Schartz NE, et al. Among authors: morel p. J Am Acad Dermatol. 2008 Apr;58(4):585-91. doi: 10.1016/j.jaad.2007.11.005. Epub 2008 Feb 20. J Am Acad Dermatol. 2008. PMID: 18068265 Clinical Trial.

2

Treatment of cutaneous sarcoidosis with thalidomide.

Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, Rybojad M. Nguyen YT, et al. Among authors: morel p. J Am Acad Dermatol. 2004 Feb;50(2):235-41. doi: 10.1016/j.jaad.2003.07.006. J Am Acad Dermatol. 2004. PMID: 14726878 Clinical Trial.

3

Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma.

Pellet C, Kerob D, Dupuy A, Carmagnat MV, Mourah S, Podgorniak MP, Toledano C, Morel P, Vérola O, Dosquet C, Hamel Y, Calvo F, Rabian C, Lebbé C. Pellet C, et al. Among authors: morel p. J Invest Dermatol. 2006 Mar;126(3):621-7. doi: 10.1038/sj.jid.5700083. J Invest Dermatol. 2006. PMID: 16410791 Free article.

4

Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.

Fardet L, Stoebner PE, Bachelez H, Descamps V, Kerob D, Meunier L, Dandurand M, Morel P, Lebbe C. Fardet L, et al. Among authors: morel p. Cancer. 2006 Apr 15;106(8):1785-9. doi: 10.1002/cncr.21791. Cancer. 2006. PMID: 16534786 Free article. Clinical Trial.

5

Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.

Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, Bachelez H, Morel P, Lebbé C. Fardet L, et al. Among authors: morel p. J Am Acad Dermatol. 2007 Apr;56(4):624-8. doi: 10.1016/j.jaad.2006.07.027. Epub 2007 Jan 22. J Am Acad Dermatol. 2007. PMID: 17240478

6

5% topical imiquimod tolerance in transplant recipients.

Ben M'barek L, Mebazaa A, Euvrard S, Frances C, Thervet E, Morel P, Menasché S, Legendre C, Lebbe C. Ben M'barek L, et al. Among authors: morel p. Dermatology. 2007;215(2):130-3. doi: 10.1159/000104264. Dermatology. 2007. PMID: 17684375

7

A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.

Ben M'barek L, Fardet L, Mebazaa A, Thervet E, Biet I, Kérob D, Morel P, Lebbe C. Ben M'barek L, et al. Among authors: morel p. Dermatology. 2007;215(3):202-5. doi: 10.1159/000106576. Dermatology. 2007. PMID: 17823515

8

Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.

Pellet C, Chevret S, Francès C, Euvrard S, Hurault M, Legendre C, Dalac S, Farge D, Antoine C, Hiesse C, Peraldi MN, Lang P, Samuel D, Calmus Y, Agbalika F, Morel P, Calvo F, Lebbé C. Pellet C, et al. Among authors: morel p. J Infect Dis. 2002 Jul 1;186(1):110-3. doi: 10.1086/341088. Epub 2002 Jun 3. J Infect Dis. 2002. PMID: 12089670

9

Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy.

Schartz NE, De La Blanchardiére A, Alaoui S, Morel P, Sigaux F, Vignon-Pennamen MD, Flageul B, Lebbé C. Schartz NE, et al. Among authors: morel p. J Am Acad Dermatol. 2003 Jul;49(1):139-41. doi: 10.1067/mjd.2003.299. J Am Acad Dermatol. 2003. PMID: 12833028

10

Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study.

Fardet L, Cabane J, Lebbé C, Morel P, Flahault A. Fardet L, et al. Among authors: morel p. J Am Acad Dermatol. 2007 Oct;57(4):604-9. doi: 10.1016/j.jaad.2007.04.018. Epub 2007 Jun 19. J Am Acad Dermatol. 2007. PMID: 17582650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,865 results

Search Page